Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Oct;7(5):602-11.
doi: 10.3748/wjg.v7.i5.602.

Liver transplantation in the UK

S R Bramhall  1 , E Minford, B Gunson, J A Buckels
Affiliations
Review

Liver transplantation in the UK

S R Bramhall et al. World J Gastroenterol. 2001 Oct.

Abstract

Introduction: This paper provides a review of the practice of liver transplantation with the main emphasis on UK practice and indications for transplantation.

Referral and assessment: This section reviews the process of referral and assessment of patients with liver disease with reference to UK practice.

Donor organs: The practice of brainstem death and cadaveric organ donation is peculiar to individual countries and rates of donation and potential areas of improvement are addressed.

Operative technique: The technical innovations that have led to liver transplantation becoming a semi-elective procedure are reviewed. Specific emphasis is made to the role of liver reduction and splitting and living related liver transplantation and how this impacts on UK practice are reviewed. The complications of liver transplan-tation are also reviewed with reference to our own unit. Immunosuppression:The evolution of immunosuppression and its impact on liver transplantation are reviewed with some reference to future protocols.

Retransplantation: The role of retransplantation is reviewed.

Outcome and survival: The results of liver transplantation are reviewed with specific emphasis on our own experience.

Future: The future of liver transplantation is addressed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evolution of european liver transplantation.
Figure 2
Figure 2
CT Scan showing HCC in cirrhotic liver with ascites and splenomegaly.
Figure 3
Figure 3
Cholangiogram showing dominant hilar stricture in a patient with PSC.
Figure 4
Figure 4
Survival following liver transplantation by disease type: birmingham series 1988-2000.
See this image and copyright information in PMC

References

    1. Hughes MD, Raskino CL, Pocock SJ, Biagini MR, Burroughs AK. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med. 1992;11:1731–1745. - PubMed
    1. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998;28:585–589. - PubMed
    1. Mutimer D, Pillay D, Shields P, Cane P, Ratcliffe D, Martin B, Buchan S, Boxall L, O'Donnell K, Shaw J, et al. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut. 2000;46:107–113. - PMC - PubMed
    1. Nery JR, Weppler D, Rodriguez M, Ruiz P, Schiff ER, Tzakis AG. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation. 1998;65:1615–1621. - PubMed
    1. Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology. 1999;29:1581–1586. - PubMed

MeSH terms